Dietary magnesium intake and metabolic syndrome in the adult population: Dose-response meta-analysis and meta-regression

Nutrients

Volumn 6, Issue 12, 2014, Pages 6005-6019

  Ju, Sang Yhun ^a   Choi, Whan Seok ^b   Ock, Sun Myeong ^a   Kim, Chul Min ^b   Kim, Do Hoon ^c  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

Magnesium intake; Meta analysis; Meta regression; Metabolic syndrome

Indexed keywords

MAGNESIUM;

BLOOD; DOSE RESPONSE; HUMAN; META ANALYSIS; METABOLIC SYNDROME X; OBSERVATIONAL STUDY; RISK ASSESSMENT; RISK FACTOR;

DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MAGNESIUM; METABOLIC SYNDROME X; OBSERVATIONAL STUDIES AS TOPIC; RISK ASSESSMENT; RISK FACTORS;

EID: 84919833432     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu6126005     Document Type: Article

References (54)

1. Reaven, G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37, 1595-1607.
2. Grundy, S.M.; Cleeman, J.I.; Daniels, S.R.; Donato, K.A.; Eckel, R.H.; Franklin, B.A.; Gordon, D.J.; Krauss, R.M.; Savage, P.J.; Smith, S.C., Jr., et al. Diagnosis and management of the metabolic syndrome: An american heart association/national heart, lung, and blood institute scientific statement. Circulation 2005, 112, 2735-2752.
3. Mottillo, S.; Filion, K.B.; Genest, J.; Joseph, L.; Pilote, L.; Poirier, P.; Rinfret, S.; Schiffrin, E.L.; Eisenberg, M.J. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J. Am. Coll. Cardiol. 2010, 56, 1113-1132.
4. Wu, S.H.; Liu, Z.; Ho, S.C. Metabolic syndrome and all-cause mortality: A meta-analysis of prospective cohort studies. Eur. J. Epidemiol. 2010, 25, 375-384.
5. Andersen, C.J.; Fernandez, M.L. Dietary strategies to reduce metabolic syndrome. Rev. Endocr. Metab. Disord. 2013, 14, 241-254.
6. Barbagallo, M.; Dominguez, L.J.; Galioto, A.; Ferlisi, A.; Cani, C.; Malfa, L.; Pineo, A.; Busardo, A.; Paolisso, G. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol. Asp. Med. 2003, 24, 39-52.
7. Elin, R.J. Magnesium: The fifth but forgotten electrolyte. Am. J. Clin. Pathol. 1994, 102, 616-622.
8. Katcher, H.I.; Legro, R.S.; Kunselman, A.R.; Gillies, P.J.; Demers, L.M.; Bagshaw, D.M.; Kris-Etherton, P.M. The effects of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome. Am. J. Clin. Nutr. 2008, 87, 79-90.
9. Guerrera, M.P.; Volpe, S.L.; Mao, J.J. Therapeutic uses of magnesium. Am. Fam. Phys. 2009, 80, 157-162.
10. Thomas, D. The mineral depletion of foods available to us as a nation (1940-2002)—A review of the 6th edition of mccance and widdowson. Nutr. Health 2007, 19, 21-55.
11. Turner, R.E.; Langkamp-Henken, B.; Littell, R.C.; Lukowski, M.J.; Suarez, M.F. Comparing nutrient intake from food to the estimated average requirements shows middle-to upper-income pregnant women lack iron and possibly magnesium. J. Am. Diet. Assoc. 2003, 103, 461-466.
12. Volpe, S.L. Magnesium, the metabolic syndrome, insulin resistance, and type 2 diabetes mellitus. Crit. Rev. Food Sci. Nutr. 2008, 48, 293-300.
13. Barbagallo, M.; Dominguez, L.J. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch. Biochem. Biophys. 2007, 458, 40-47.
14. Corica, F.; Corsonello, A.; Ientile, R.; Cucinotta, D.; Di Benedetto, A.; Perticone, F.; Dominguez, L.J.; Barbagallo, M. Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J. Am. Coll. Nutr. 2006, 25, 210-215.
15. Guerrero-Romero, F.; Rodríguez-Morán, M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol. 2002, 39, 209-213.
16. Guerrero-Romero, F.; Rodríguez-Morán, M. Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes Metab. Res. Rev. 2006, 22, 471-476.
17. Yu, Y.; Cai, Z.; Zheng, J.; Chen, J.; Zhang, X.; Huang, X.F.; Li, D. Serum levels of polyunsaturated fatty acids are low in Chinese men with metabolic syndrome, whereas serum levels of saturated fatty acids, zinc, and magnesium are high. Nutr. Res. 2012, 32, 71-77.
18. Ford, E.S.; Li, C.; McGuire, L.C.; Mokdad, A.H.; Liu, S. Intake of dietary magnesium and the prevalence of the metabolic syndrome among U.S. Adults. Obesity 2007, 15, 1139-1146.
19. He, K.; Liu, K.; Daviglus, M.L.; Morris, S.J.; Loria, C.M.; van Horn, L.; Jacobs, D.R., Jr.; Savage, P.J. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 2006, 113, 1675-1682.
20. Song, Y.; Ridker, P.M.; Manson, J.E.; Cook, N.R.; Buring, J.E.; Liu, S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 2005, 28, 1438-1444.
21. Bo, S.; Durazzo, M.; Guidi, S.; Carello, M.; Sacerdote, C.; Silli, B.; Rosato, R.; Cassader, M.; Gentile, L.; Pagano, G. Dietary magnesium and fiber intakes and inflammatory and metabolic indicators in middle-aged subjects from a population-based cohort. Am. J. Clin. Nutr. 2006, 84, 1062-1069.
22. Noori, N.; Nafar, M.; Poorrezagholi, F.; Ahmadpoor, P.; Samadian, F.; Firouzan, A.; Einollahi, B. Dietary intakes of fiber and magnesium and incidence of metabolic syndrome in first year after renal transplantation. J. Ren. Nutr. 2010, 20, 101-111.
23. Liberati, A.; Altman, D.G.; Tetzlaff, J.; Mulrow, C.; Gøtzsche, P.C.; Ioannidis, J.P.; Clarke, M.; Devereaux, P.J.; Kleijnen, J.; Moher, D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med. 2009, 339, b2700, doi:10.1136/bmj.b2700.
24. Kim, S.Y.; Park, J.E.; Lee, Y.J.; Seo, H.J.; Sheen, S.S.; Hahn, S.; Jang, B.H.; Son, H.J. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J. Clin. Epidemiol. 2013, 66, 408-414.
25. DerSimonian, R.; Laird, N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7, 177-188.
26. Thompson, S.G.; Higgins, J.P. How should meta-regression analyses be undertaken and interpreted? Stat. Med. 2002, 21, 1559-1573.
27. Greenland, S.; Longnecker, M.P. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am. J. Epidemiol. 1992, 135, 1301-1309.
28. Symons, M.J.; Moore, D.T. Hazard rate ratio and prospective epidemiological studies. J. Clin. Epidemiol. 2002, 55, 893-899.
29. Huang, J.H.; Lu, Y.F.; Cheng, F.C.; Lee, J.N.; Tsai, L.C. Correlation of magnesium intake with metabolic parameters, depression and physical activity in elderly type 2 diabetes patients: A cross-sectional study. Nutr. J. 2012, 11, 41.
30. Tsou, M.T. Metabolic syndrome in metabolic obese, non-obese elderly in northern Taiwan. Adv. Aging Res. 2012, 1, 53-59.
31. Higgins, J.P.; Thompson, S.G.; Deeks, J.J.; Altman, D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327, 557-560.
32. Al-Daghri, N.M.; Khan, N.; Alkharfy, K.M.; Al-Attas, O.S.; Alokail, M.S.; Alfawaz, H.A.; Alothman, A.; Vanhoutte, P.M. Selected dietary nutrients and the prevalence of metabolic syndrome in adult males and females in saudi arabia: A pilot study. Nutrients 2013, 5, 4587-4604.
33. Choi, M.K.; Bae, Y.J. Relationship between dietary magnesium, manganese, and copper and metabolic syndrome risk in korean adults: The Korea National Health And Nutrition Examination Survey (2007-2008). Biol. Trace Elem. Res. 2013, 156, 56-66.
34. McKeown, N.M.; Jacques, P.F.; Zhang, X.L.; Juan, W.; Sahyoun, N.R. Dietary magnesium intake is related to metabolic syndrome in older Americans. Eur. J. Nutr. 2008, 47, 210-216.
35. Volpe, S.L. Magnesium in disease prevention and overall health. Adv. Nutr. 2013, 4, 378S-383S.
36. Hadjistavri, L.S.; Sarafidis, P.A.; Georgianos, P.I.; Tziolas, I.M.; Aroditis, C.P.; Hitoglou-Makedou, A.; Zebekakis, P.E.; Pikilidou, M.I.; Lasaridis, A.N. Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile. Med. Sci. Monit. 2010, 16, CR307-CR312.
37. Song, Y.; He, K.; Levitan, E.B.; Manson, J.E.; Liu, S. Effects of oral magnesium supplementation on glycaemic control in type 2 diabetes: A meta-analysis of randomized double-blind controlled trials. Diabet. Med. 2006, 23, 1050-1056.
38. Wang, J.; Persuitte, G.; Olendzki, B.C.; Wedick, N.M.; Zhang, Z.; Merriam, P.A.; Fang, H.; Carmody, J.; Olendzki, G.F.; Ma, Y. Dietary magnesium intake improves insulin resistance among non-diabetic individuals with metabolic syndrome participating in a dietary trial. Nutrients 2013, 5, 3910-3919.
39. Suárez, A.; Pulido, N.; Casla, A.; Casanova, B.; Arrieta, F.J.; Rovira, A. Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia 1995, 38, 1262-1270.
40. Hruby, A.; Ngwa, J.S.; Renström, F.; Wojczynski, M.K.; Ganna, A.; Hallmans, G.; Houston, D.K.; Jacques, P.F.; Kanoni, S.; Lehtimäki, T., et al. Higher magnesium intake is associated with lower fasting glucose and insulin, with no evidence of interaction with select genetic loci, in a meta-analysis of 15 charge consortium studies. J. Nutr. 2013, 143, 345-353.
41. Kass, L.; Weekes, J.; Carpenter, L. Effect of magnesium supplementation on blood pressure: A meta-analysis. Eur. J. Clin. Nutr. 2012, 66, 411-418.
42. Soltani, N.; Keshavarz, M.; Dehpour, A.R. Effect of oral magnesium sulfate administration on blood pressure and lipid profile in streptozocin diabetic rat. Eur. J. Pharmacol. 2007, 560, 201-205.
43. Olatunji, L.A.; Soladoye, A.O. Increased magnesium intake prevents hyperlipidemia and insulin resistance and reduces lipid peroxidation in fructose-fed rats. Pathophysiology 2007, 14, 11-15.
44. Bo, S.; Pisu, E. Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Curr. Opin. Lipidol. 2008, 19, 50-56.
45. Beydoun, M.A.; Gary, T.L.; Caballero, B.H.; Lawrence, R.S.; Cheskin, L.J.; Wang, Y. Ethnic differences in dairy and related nutrient consumption among us adults and their association with obesity, central obesity, and the metabolic syndrome. Am. J. Clin. Nutr. 2008, 87, 1914-1925.
46. Drenick, E.J. The influence of ingestion of calcium and other soap-forming substances on fecal fat. Gastroenterology 1961, 41, 242-244.
47. Cahill, F.; Shahidi, M.; Shea, J.; Wadden, D.; Gulliver, W.; Randell, E.; Vasdev, S.; Sun, G. High dietary magnesium intake is associated with low insulin resistance in the newfoundland population. PLoS One 2013, doi:10.1371/journal.pone.0058278.
48. Freedman, L.S.; Schatzkin, A.; Wax, Y. The impact of dietary measurement error on planning sample size required in a cohort study. Am. J. Epidemiol. 1990, 132, 1185-1195.
49. Freudenheim, J.L.; Marshall, J.R. The problem of profound mismeasurement and the power of epidemiological studies of diet and cancer. Nutr. Cancer 1988, 11, 243-250.
50. Höfler, M. The effect of misclassification on the estimation of association: A review. Int. J. Methods Psychiatr. Res. 2005, 14, 92-101.
51. Copeland, K.T.; Checkoway, H.; McMichael, A.J.; Holbrook, R.H. Bias due to misclassification in the estimation of relative risk. Am. J. Epidemiol. 1977, 105, 488-495.
52. Thompson, F.E.; Kipnis, V.; Midthune, D.; Freedman, L.S.; Carroll, R.J.; Subar, A.F.; Brown, C.C.; Butcher, M.S.; Mouw, T.; Leitzmann, M., et al. Performance of a food-frequency questionnaire in the US NIH-AARP (National Institutes of Health-American Association of Retired Persons) diet and health study. Public Health Nutr. 2008, 11, 183-195.
53. Dong, J.Y.; Xun, P.; He, K.; Qin, L.Q. Magnesium intake and risk of type 2 diabetes: Meta-analysis of prospective cohort studies. Diabetes Care 2011, 34, 2116-2122.
54. Qu, X.; Jin, F.; Hao, Y.; Li, H.; Tang, T.; Wang, H.; Yan, W.; Dai, K. Magnesium and the risk of cardiovascular events: A meta-analysis of prospective cohort studies. PLoS One 2013, doi:10.1371/journal.pone.0057720. soulfree@catholic.ac.kr